Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Avanos Medical (AVNS) Gross Margin (2016 - 2025)

Avanos Medical (AVNS) has disclosed Gross Margin for 13 consecutive years, with 47.54% as the latest value for Q4 2025.

  • Quarterly Gross Margin fell 703.0% to 47.54% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 50.47% through Dec 2025, down 497.0% year-over-year, with the annual reading at 50.47% for FY2025, 497.0% down from the prior year.
  • Gross Margin hit 47.54% in Q4 2025 for Avanos Medical, down from 48.37% in the prior quarter.
  • In the past five years, Gross Margin ranged from a high of 90.22% in Q4 2021 to a low of 45.98% in Q2 2021.
  • Historically, Gross Margin has averaged 55.68% across 5 years, with a median of 54.69% in 2024.
  • Biggest five-year swings in Gross Margin: soared 4347bps in 2021 and later plummeted -3356bps in 2022.
  • Year by year, Gross Margin stood at 90.22% in 2021, then plummeted by -37bps to 56.66% in 2022, then decreased by -3bps to 54.82% in 2023, then fell by 0bps to 54.57% in 2024, then fell by -13bps to 47.54% in 2025.
  • Business Quant data shows Gross Margin for AVNS at 47.54% in Q4 2025, 48.37% in Q3 2025, and 52.63% in Q2 2025.